《《精编》医药研发行业薪酬福利调查报告》由会员分享，可在线阅读，更多相关《《精编》医药研发行业薪酬福利调查报告（95页珍藏版）》请在金锄头文库上搜索。
1、EngageTalent ImproveProductivity Hewitt2010CPRDSResultsSharing Sept 21th2010 OverviewofHewittR DCenterStudy Hewitt2010CPRDSParticipantList Totaling31 Today sContent OverallMarketUpdatePharmaIndustryandR DSectorOverviewEngageEmployeetoImproveProductivityBasedonHewittEngagementModelAppendixEngagementD
2、riverDefinitionAboutHewitt Marco economicSituationintheWorld Datasources 1 InternationalMonetaryFundDatabase2 ChinaCPIfromNationalBureauofStatistics PRC3 EconomistIntelligenceUnit Australia India Japan Singapore Thailand UAE China ChinaMarketMovement Datasources 1 NationalBureauofStatistics PRC2 Hew
3、ittChinaSalaryIncreaseSurvey1995 20103 InternationalMonetaryFundDatabase4 OECDStatistics China sSourceofGrowthisShifting Chinahighgrowthinthepastyearshasbeenmainlydrivenbyimprovementinallocativeefficiency particularlyreallocationofhumancapitalRuralvs Urban Centralprobablyforanother10 15years Sustain
4、abilityofgrowthinfuturemuchdependsonimprovementinproductiveefficiency thatis technologicalinnovation AllocativeEfficiency productionfactorsmovefromlowproductivity lowvaluesectorstohighproductivity highvaluesectors pricemustberight ProductiveEfficiency Increaseinproductivitythroughtechnologicalinnova
5、tion incentiveforinnovationmustberight DataSource ProfessorWeiyingZhang PekingUniversity ChinaBeatingJapanintermofShareofTotalGlobalR DSpending DataSource Battelle R DMagazine TheGovernmentistheMainSourceofChinaR DInvestment DataSource OrganizationofEconomicCooperationandDevelopment2009 BreakdownofC
6、hineseR DInvestment DistributionofChinesePatents DataSource QueenMaryUniversityofLondon 2009 EmergingEconomicsDrivingGlobalR DGrowth DataSource R DMagazine Battelle OECD IMF CIA 2008 ScientistsandEngineers MillionPeople R Das GDP Today sContent OverallMarketUpdatePharmaIndustryandR DSectorOverviewEn
7、gageEmployeetoImproveProductivityBasedonHewittEngagementModelAppendixEngagementDriverDefinitionAboutHewitt SlowingGlobalPharmaGrowthwithParmergingGrowthOutpacingtheRest DataSource MinistryofHealth IMS CITICS MarketSales BillionUSD IncreaseRate PharmaMarketGrowthintheWorld PharmaMarketGrowthintheWorl
8、d 40 AmongGlobalInnovationTop20CompaniesarefromPharmaIndustry IncreasingExpenseinPharmaR DbutDecreasingOutput Strongneedstoimprove 1 CapitalEfficiency 2 R Dproductivity DataSource PhRMA 2007 FDA TheRoadtoPositiveR DReturns ImproveProductivity IncreaseROI Scientificinnovationisnottheonlyroutetohigher
9、R Dproductivity Attentiontothefamiliarmanagementareasofcost speed anddecisionmakingcanstillreaprewards DataSource MicKinseyQuarterly Feb 2010 CostOrganizationalandProcurementIssuesMoreAggressiveoutsourceselectednoncoreactivitiestolow costlocationsReducethecostsassociatedwithdrugfailuresbyFocusingont
10、heactivitiestrulyreducingriskoffailureSharingriskwithothers SpeedClinicaldevelopmentplanning goodvs poor PatientRecruiting quickvs slow Siteandinvestigatormanagement optimalvs suboptimal DecisionMakingShiftcompoundattritiontoearlierstagesChoiceofcompoundsforInvestment AllMajorBigPharmasHaveSteppedup
11、theirInvestmentsinChinainthePastOneorTwoYears Q1 2009 Q2 2009 Q3 2009 Q4 2009 Q1 2010 Bayer Scheringwillinvest100milEurotoestablishitsR DcenterinBeijingtoenhanceitsglobalR Dcapability Johnson JohnsonannouncedthattheywillbuildupitsAPACR DcenterinShanghaitoconsolidateitsR DcapabilityinBeijing Mumbaian
12、dBangaloreandwillhavewidecooperationwithuniversitiesinChina AstraZenecainvesttoestablishitsnewChinaoperationcenterandpartofitsAPACfunctioninShanghaiItsnewR Dcenterwillstarttousein2012inShanghaiZhangJiangHigh TechPark Novartisinvested 1BinR DinChinaoverthenext5yearsandwillpay 125milliontobuyan85 stak
13、einChinesevaccinemakerZheijangTianyuanBio Pharmaceutical RocheannouncedthatitsAsiaoperationscenterisbeingestablishedinShanghaiandthatChinawillserveasacoredevelopmentregion atthesamelevelastheUSandGermany PfizerPfizerEMPresidentannouncedinteresttopursueacquisitionsinChinatoaccelerategrowthPfizerexpan
14、ditsmanufacturerplantandR DcapabilityinChina MerckSeronoplanstoestablishitsglobalR DcenterinBeijingandwillkeepinvestabout150milEuroforthisnewcenter NovoNordiskplanstodoubleinvestmentinChinaR Din3yearstobethe2ndlargestglobalR Dcenter BIToinvest 240MinR DandmanufacturinginChina GSKShanghaiR Dcentercon
15、solidatedasthesoleglobalneuroscienceR Dsite Q2 2010 Sanofi AventisDecidedtoestablishitsAPR DcenterinShanghai CROBenefitsfromPharmaMovingUptheValueChain CROinChina Todayataglace298registeredChinese basedclinicaltrialsin2007 ayear on yeargrowthof41 RapiddevelopmentinbiotechcapabilityMovementtowardsgen
16、omicsandgenetherapyIncreasingabilitytomeetwesternstandardsindrugqualityandsafety TheChallengesThelackofenforcementofIPlawsThedifficultiesinrecruitingexperiencedtalentforprojectmanagementaswellasinretainingthemLargelyfragmented AnoutsourceddestinationDespitetheproportionallysmallbaseof1 ofthetotalglobalCROrevenue China sattractivenessattributableto Costandtimesavings suggestively50 Talentpool Patientpool Animalresources Rapideconomicdevelopment TheTrendsEmergenceofone stopserviceprovider fromdrug
